Dr. Erica Holland, MD is a sub-specialist in the Division of Maternal and Fetal Medicine. She received her BA from Cornell University and her MD from the University of Massachusetts Medical School. She completed a Residency in Obstetrics and Gynecology from Boston University/Boston Medical Center, a Fellowship in Maternal and Fetal Medicine from Brigham and Women’s Hospital, and a Fellowship in Bioethics from the Center for Bioethics at Harvard Medical School.
She is an attending physician with the multidisciplinary program Project RESPECT, caring for patients with substance use disorder affecting pregnancy and the postpartum period. Her clinical interests also include hypertensive disorders of pregnancy, autoimmune disorders of pregnancy, histories of preterm birth, cervical insufficiency, intrauterine demise, and obstetrical ultrasound.
Her research interests include the role of urine drug testing in pregnancy, the management of opioid use disorder during pregnancy, pain management during and after childbirth, and ethical issues surrounding the care of pregnant individuals.
Diversity, Equity, Inclusion and Accessibility
My past experience as a resident at Boston Medical Center afforded me with the humbling reality that stigma and mistrust deeply affect medical care. This was true for many of my patients with stigmatized medical conditions such as opioid use disorder and HIV, and it was true for many of my patients of color who faced bias with every hospital interaction in the setting of profound historical trauma. My motivation to return to Boston Medical Center after completing a fellowship in Maternal and Fetal Medicine was centered around a determination to chip away at this mistrust and stigma through compassionate, patient-centered, evidence-based care, and through research. Specific examples of my work include my role as an attending physician in Project RESPECT, a multidisciplinary program for pregnant patients with substance use disorder, my advocacy work regarding urine drug testing in pregnancy, and my research addressing racial disparities in postpartum pain management.
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
to make corrections and additions.
O'Rourke-Suchoff D, Sobel L, Holland E, Perkins R, Saia K, Bell S. The labor and birth experience of women with opioid use disorder: A qualitative study. Women Birth. 2020 Nov; 33(6):592-597.View Related Profiles. PMID: 31987751
Holland E, Sudhof LS, Zera C. Optimal pain management for cesarean delivery. Int Anesthesiol Clin. 2020; 58(2):42-49. PMID: 32039926
Holland E, Bateman BT, Cole N, Taggart A, Robinson LA, Sugrue R, Xu X, Robinson JN. Evaluation of a Quality Improvement Intervention That Eliminated Routine Use of Opioids After Cesarean Delivery. Obstet Gynecol. 2019 01; 133(1):91-97. PMID: 30531571
Sobel L, O'Rourke-Suchoff D, Holland E, Remis K, Resnick K, Perkins R, Bell S. Pregnancy and Childbirth After Sexual Trauma: Patient Perspectives and Care Preferences. Obstet Gynecol. 2018 12; 132(6):1461-1468.View Related Profiles. PMID: 30399100
Holland E, Michelis LD, Sonalkar S, Curry CL. Barriers to Immediate Post-placental Intrauterine Devices among Attending Level Educators. Womens Health Issues. 2015 Jul-Aug; 25(4):355-8. PMID: 26048758
Holland E, Moore Simas TA, Doyle Curiale DK, Liao X, Waring ME. Self-reported pre-pregnancy weight versus weight measured at first prenatal visit: effects on categorization of pre-pregnancy body mass index. Matern Child Health J. 2013 Dec; 17(10):1872-8. PMID: 23247668; PMCID: PMC3622142; DOI: 10.1007/s10995-012-1210-9;
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.